First Citizens Bank & Trust Co. lowered its stake in Walgreens Boots Alliance Inc (NASDAQ:WBA) by 80.1% in the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 3,815 shares of the pharmacy operator’s stock after selling 15,400 shares during the quarter. First Citizens Bank & Trust Co.’s holdings in Walgreens Boots Alliance were worth $277,000 as of its most recent SEC filing.
Other institutional investors have also recently added to or reduced their stakes in the company. Hudock Capital Group LLC increased its stake in shares of Walgreens Boots Alliance by 0.5% in the second quarter. Hudock Capital Group LLC now owns 1,306 shares of the pharmacy operator’s stock valued at $102,000 after buying an additional 6 shares during the period. Westside Investment Management Inc. increased its stake in shares of Walgreens Boots Alliance by 10.4% in the second quarter. Westside Investment Management Inc. now owns 1,325 shares of the pharmacy operator’s stock valued at $102,000 after buying an additional 125 shares during the period. Zions Bancorporation increased its stake in shares of Walgreens Boots Alliance by 983.3% in the third quarter. Zions Bancorporation now owns 1,365 shares of the pharmacy operator’s stock valued at $105,000 after buying an additional 1,239 shares during the period. IHT Wealth Management LLC increased its position in Walgreens Boots Alliance by 46.3% during the 2nd quarter. IHT Wealth Management LLC now owns 6,946 shares of the pharmacy operator’s stock valued at $135,000 after purchasing an additional 2,199 shares during the period. Finally, Bristlecone Advisors LLC acquired a new stake in Walgreens Boots Alliance during the 3rd quarter valued at approximately $135,000. 61.20% of the stock is owned by institutional investors.
Walgreens Boots Alliance Inc (WBA) opened at $75.78 on Thursday. Walgreens Boots Alliance Inc has a twelve month low of $63.82 and a twelve month high of $88.00. The company has a debt-to-equity ratio of 0.48, a current ratio of 0.96 and a quick ratio of 0.47. The stock has a market capitalization of $75,050.00, a price-to-earnings ratio of 20.93, a P/E/G ratio of 1.29 and a beta of 1.22.
Walgreens Boots Alliance (NASDAQ:WBA) last issued its earnings results on Thursday, January 4th. The pharmacy operator reported $1.28 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $1.27 by $0.01. Walgreens Boots Alliance had a return on equity of 19.15% and a net margin of 3.19%. The company had revenue of $30.74 billion for the quarter, compared to analysts’ expectations of $30.39 billion. During the same period last year, the business earned $1.10 EPS. Walgreens Boots Alliance’s quarterly revenue was up 7.9% compared to the same quarter last year. analysts predict that Walgreens Boots Alliance Inc will post 5.7 earnings per share for the current year.
Walgreens Boots Alliance declared that its Board of Directors has authorized a stock repurchase plan on Wednesday, October 25th that authorizes the company to buyback $1.00 billion in outstanding shares. This buyback authorization authorizes the pharmacy operator to repurchase shares of its stock through open market purchases. Stock buyback plans are generally an indication that the company’s management believes its shares are undervalued.
In other Walgreens Boots Alliance news, Director William C. Foote sold 2,736 shares of the firm’s stock in a transaction on Thursday, November 2nd. The stock was sold at an average price of $67.37, for a total transaction of $184,324.32. Following the transaction, the director now directly owns 16,415 shares in the company, valued at approximately $1,105,878.55. The sale was disclosed in a document filed with the SEC, which is available through this hyperlink. Also, Director John Anthony Lederer acquired 20,000 shares of the company’s stock in a transaction on Thursday, October 26th. The shares were bought at an average price of $67.00 per share, for a total transaction of $1,340,000.00. Following the completion of the purchase, the director now owns 50,000 shares in the company, valued at approximately $3,350,000. The disclosure for this purchase can be found here. 14.80% of the stock is owned by company insiders.
A number of research firms have weighed in on WBA. Needham & Company LLC reissued a “buy” rating and set a $88.00 target price (up previously from $86.00) on shares of Walgreens Boots Alliance in a research report on Wednesday, January 10th. BidaskClub raised shares of Walgreens Boots Alliance from a “sell” rating to a “hold” rating in a research report on Wednesday, January 10th. Loop Capital set a $90.00 target price on shares of Walgreens Boots Alliance and gave the company a “buy” rating in a research report on Thursday, October 26th. Robert W. Baird reissued an “outperform” rating and set a $80.00 target price (down previously from $90.00) on shares of Walgreens Boots Alliance in a research report on Thursday, October 19th. They noted that the move was a valuation call. Finally, Citigroup decreased their target price on shares of Walgreens Boots Alliance from $95.00 to $81.00 and set a “buy” rating for the company in a research report on Thursday, November 2nd. Nine research analysts have rated the stock with a hold rating, fifteen have given a buy rating and one has assigned a strong buy rating to the stock. The stock presently has an average rating of “Buy” and a consensus target price of $86.20.
ILLEGAL ACTIVITY NOTICE: “First Citizens Bank & Trust Co. Reduces Stake in Walgreens Boots Alliance Inc (WBA)” was published by TrueBlueTribune and is owned by of TrueBlueTribune. If you are reading this story on another domain, it was copied illegally and republished in violation of United States & international trademark & copyright legislation. The legal version of this story can be accessed at https://www.truebluetribune.com/2018/01/18/first-citizens-bank-trust-co-reduces-stake-in-walgreens-boots-alliance-inc-wba.html.
About Walgreens Boots Alliance
Walgreens Boots Alliance, Inc (Walgreens Boots Alliance) is a holding company. The Company is a global pharmacy-led, health and wellbeing enterprise. Walgreens Boots Alliance operates through three divisions, including Retail Pharmacy USA, Retail Pharmacy International and Pharmaceutical Wholesale. The Company’s products are marketed under a number of brands, which include No7, the Botanics range, Almus (generic medicines), Boots Pharmaceuticals and Soap & Glory (bathing and beauty brand).
Want to see what other hedge funds are holding WBA? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Walgreens Boots Alliance Inc (NASDAQ:WBA).
Receive News & Ratings for Walgreens Boots Alliance Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Walgreens Boots Alliance and related companies with MarketBeat.com's FREE daily email newsletter.